Medical Doctor degree from Federal University of Uberlândia (UFU-MG), Master's Degree in Psychopharmacology and PhD in Psychobiology from the Federal University of São Paulo (UNIFESP), Post-Doctorate in Therapeutic and Behavioral Pharmacology from the Louisiana State University Health Science Center. She is currently a Full Professor at the Federal University of Espírito Santo - ES and works in the area of Neurosciences, with emphasis on Cognitive Sciences and Neuropsychopharmacology, mainly in the following subjects: Pre Frontal Cortex, Working Memory, Executive Functions, Cognitive Disorders, Substance Use Disorder, ERP (Event Related Potentials), Neuromodulation by Non-Invasive Brain Stimulation (Transcranial and Epidural), and more recently has invested in the joint elaboration (engineering and psychology) of a Neurofeedback system for application in neurobehavioral disorders.

Adrienne holds a first class honors degree in theoretical physics, working with Bob Dewar in plasma physics, from ANU in Canberra, Australia and completed her PhD in physics at the Weizmann Institute, with Itamar Procaccia working on turbulence, in 1998. She moved into neuroscience research as a postdoc with Bill Bialek at NEC Research Institute in Princeton, then with Michael Berry at Princeton University. She joined the faculty of UW’s Department of Physiology and Biophysics in 2004 and became a co-director of the WRF Institute for Neuroengineering in 2014. With Eric Shea-Brown, she co-directs the Computational Neuroscience Center’s research and educational program at UW. 

Patrick is a Professor in the Van Cleef Centre for Nervous Diseases, Department of Neuroscience, within the Central Clinical School, and Consultant Neurologist and Head of the Epilepsy Clinic at Alfred Health.
He is a medical specialist in neurology and an international authority in epileptology and antiepileptic drug development. 
Professor Kwan’s research portfolio encompasses both applied basic science and clinical aspects to improve the treatment outcomes of epilepsy. His research is focused on understanding the effects of long term treatment, identifying factors that affect outcomes, mechanisms of drug resistance, identifying novel molecular targets for the treatment and prevention of epilepsy and translating research findings into the practice of personalized medicine for epilepsy.